Don’t use the Neoplasm Table with Neuroendocrine Tumors (NET)

Don’t use the Neoplasm Table with Neuroendocrine Tumors (NET)

Previously neuroendocrine tumors (NETs) were called carcinoid tumors and some clinicians will continue to call them carcinoid tumors.  This is a physician query opportunity.

They are not universally consistent in their characteristics. Some neuroendocrine cancer grows quickly while others grow slowly. Most of these tumors develop in the lungs, appendix, small intestine, rectum, testicles, ovaries, and pancreas, but and essentially, can be found anywhere. Some tumors can produce hormones, while others don’t.  Symptoms may vary depending on the part of the body affected by the tumor.[i] They are comprised of cells that may produce hormonal syndromes which impact the normal hormonal balance that supports body system functions.

NETs can be malignant or benign.  Unfortunately, the clinical documentation we see as coders, does not always clearly specify malignant or benign.  So, here’s another physician query opportunity!  If the documentation does not specify the NET as malignant or benign, the default is benign.  This path to benign is per the indexing of tumor, neuroendocrine:  D3A.8-Other benign carcinoid tumors

Often this neuroendocrine tumor is abbreviated in the documentation.  Look for NET or other abbreviations such as PNET or PanNET for pancreatic NET, GINET for gastrointestinal NET, and WDNET or PD NET for well-differentiated or poorly-differentiated neuroendocrine tumor.

IMPORTANT:  Neuroendocrine tumors have their own set of codes. They are not coded from the neoplasm table codes. I can’t explain the logic for not including them in the table!

  • Category D3A.00-D3A.8 are Benign carcinoid tumors of specific sites and includes a code for unspecified site
  • Category C7A.00-C7A.098-Malignant Carcinoids by site
  • Category C7B.00-C7B.09-Secondary Carcinoid Tumors by site
  • Category C7A.1-Malignant poorly differentiated neuroendocrine tumors (Any Primary site); Includes High Grade
  • Category C7A.8-Other malignant neuroendocrine tumors (Any Primary site)
  • Category C7B.1-Secondary Merkel cell carcinoma (NOTE: Do not use secondary codes from the neoplasm table) Primary Merkel cell is category C4A
  • Category C7B.8-Other secondary neuroendocrine tumors. (NOTE:  Do not use secondary codes from the neoplasm table)

These tumors arise from epithelium; thus, malignant tumors in this group are referred to as neuroendocrine carcinomas.[ii]  NETs can spread to the bones, brain, lungs, and other locations. The type and location of the cancer influences the treatments.  Treatment may include surgery, radiation, targeted therapy, or a combination of these treatment techniques. Finally, many of the tumors in the categories above yield an HCC and some a RxHCC.

If you remember one thing about NETs, it’s to NOT use the neoplasm table.  Coders and clinical documentation integrity specialists play a vital role in accurately capture the documentation needed to apply a specific code for NETs and help future clinicians prepare an appropriate care plan for the patient.

About the Author:  Pam Scott is Vice President of Coding Support and Compliance Services at St. Louis-based First Class Solutions, Inc.  She is the firm’s educator, a frequent speaker at State HIM meetings, and serves as a coding compliance auditor for several of the firm’s clients.


https://www.sayyestohope.org/neuroendocrin/#:~:text=In%20the%20later%20stages%20of,%2C%20difficulty%20breathing%2C%20and%20diarrhea.

https://librepathology.org/wiki/Neuroendocrine_neoplasms

Facebook
Twitter
LinkedIn

Pamela Scott, RHIT, CCS, CCDS, CRC, AHIMA-Approved ICD-10 CM/PCS Trainer

Pam provides coding support and coding compliance services for our clients. She has served as a coding mentor to many of our clients’ coders and especially those new to the coding field. Our clients often compliment her on her caring attitude and quality of her work. Certified in risk-adjustment coding (HCCs), Pam has participated in governmental audits of Medicare Advantage plans and can assist clients in understanding the nuances of this coding system

Related Stories

Understanding the Pitfalls of Policy

Policies have the potential to be quite a double-edged sword. Generally speaking, managers love policies, and I think there are several reasons for this. Perhaps the

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

AI, Audits, and the Future of the Revenue Cycle

Artificial intelligence is rapidly transforming healthcare revenue cycle operations, from coding and auditing to compliance and denials. Join industry leaders Pam Warren (MaineHealth) and Raemarie Jimenez (AAPC) for a live fireside chat exploring how AI is changing workflows, workforce roles, payer-provider dynamics, and compliance risk—and what organizations should be doing now to prepare.

June 17, 2026

Trending News

Featured Webcasts

Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules – Part 2

Medicare regulations are complex and even seasoned professionals struggle to apply them consistently. Due to overwhelming demand, Dr. Hirsch returns for Part 2 of Ask Dr. Hirsch: Clarifying Medicare’s Most Misunderstood Rules to answer even more of Medicare’s most misunderstood questions, covering inpatient status, observation, SNF access, Medicare Advantage denials, and more. Join Dr. Hirsch as he provides clear, referenced answers to real-world questions submitted by your peers, helping you navigate Medicare compliance with confidence and clarity.

June 18, 2026

Reengineering Utilization Management: Building an Adaptive Model for the New Payer Era

Traditional utilization management models can no longer keep pace with regulatory shifts, payer scrutiny, and operational pressures. In this webcast, Tiffany Ferguson, LMSW, CMAC, ACM, ACPA-C, introduces an Adaptive Model strategy that modernizes UM through role specialization, technology-driven workflows, and proactive, team-based processes. Attendees will learn how to restructure programs to improve efficiency, strengthen clinical collaboration, and enhance financial performance in a rapidly changing healthcare environment.

May 20, 2026

Compliance for the Inpatient Psychiatric Facility (IPF-PPS): Minimizing Federal Audit Findings by Strengthening Best Practices

Federal auditors are intensifying their focus on inpatient psychiatric facilities, using advanced data analytics to spotlight outliers and pursue high‑dollar repayments. In this high‑impact webcast, Michael Calahan, PA, MBA, Compliance Officer and V.P., Hospital & Physician Compliance, breaks down what regulators are really targeting in IPF-PPS admissions, documentation, treatment and discharge planning. Attendees will learn practical steps to tighten processes, avoid common audit triggers and protect reimbursement and reduce the risk of multimillion-dollar repayment demands.

April 9, 2026

Mastering MDM for Accurate Professional Fee Coding

In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.

March 31, 2026

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

This Memorial Day, we honor those who gave all for our freedom. Take 20% off sitewide through May 29 with code MEMORIAL26 at checkout

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24